Cancer

August 26, 2013

Tumor factor spurs blood vessel growth

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

By Leigh MacMillan
August 22, 2013

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

By Leigh MacMillan
Illustration of human intestinal tract
August 15, 2013

$5.2M NIH grant bolsters colorectal cancer research

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

By Bill Snyder
August 15, 2013

Komen grants bolster breast cancer research

Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research.

By VUMC News and Communications
August 12, 2013

Noninvasive test detects stomach bug

A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer.

By Leigh MacMillan
August 1, 2013

Study explores race differences of lung cancer risk

Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups.

By VUMC News and Communications
August 1, 2013

‘Undy’ event to raise colon cancer funds, awareness

Vanderbilt will add a new race event, the 2013 Nashville Undy 5000, to the list of affiliated events for the upcoming fall season.
By VUMC News and Communications
July 11, 2013

Brown to lead new Interventional Oncology division

Daniel Brown, M.D., has been named chief of Interventional Oncology, a new division within the Department of Radiology and Radiological Sciences.
By VUMC News and Communications
June 24, 2013

Predicting cancer’s response to therapy

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.
By Leigh MacMillan
June 20, 2013

Disease linked to cell traffic jams

Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface.
By Leigh MacMillan
June 10, 2013

Factor’s yin-yang tumor effects

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.
By Leigh MacMillan
June 6, 2013

Leukemia & Lymphoma Society honors Ohi’s research

Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma.
By VUMC News and Communications
May 30, 2013

Study finds state-to-state variation in benign lung disease diagnosis

A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer.
By VUMC News and Communications